BioSpace News Archive

Drug Development

Synlogic Publishes Preclinical Data Supporting Development of SYNB1618, a Synthetic Biotic™ Medicine as a Potential Treatment for Phenylketonuria

Preclinical studies published in Nature Biotechnology identify key biomarkers of SYNB1618 activity in healthy animals and disease models

August 13, 2018
·
7 min read
Renal Anemia| A Drug Pipeline Analysis Report 2018| Technavio

Technavio has announced their latest pipeline analysis report on the drug pipeline for renal anemia.

August 13, 2018
·
4 min read
Business

Johns Hopkins Medicine Awards Medline Prime Vendor Distribution Agreement

Streamlining product categories, standardization fuel non-clinical cost savings

August 13, 2018
·
2 min read
Pharm Country

OncLive® Presents the Latest State of the Science Summit™ on Advanced Non-Small Cell Lung Cancer on August 23, 2018

The summit will feature experts from the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.

August 13, 2018
·
2 min read
Business

Zelluna Immunotherapy appoints Dr. Namir Hassan as Chief Scientific Officer

Zelluna Immunotherapy, the biotechnology company specializing in T-cell receptor (TCR) immunotherapies targeting a broad range of solid cancers with a high unmet medical need, today announces the appointment of Dr. Namir Hassan as chief scientific officer (CSO).

August 13, 2018
·
2 min read
Business

Certis Oncology Partners With Reveal Biosciences to Offer Advanced Pre-Clinical Oncology Services

Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an innovative, next-generation suite of pre-clinical oncology services.

August 13, 2018
·
3 min read
Business

Ekso Bionics Appoints Jack Glenn as Chief Financial Officer

Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that John (Jack) Glenn has been appointed to the position of Chief Financial Officer.

August 13, 2018
·
4 min read
Business

Vanda Pharmaceuticals Announces the Appointment of General Counsel

Vanda Pharmaceuticals, Inc. (Vanda) (Nasdaq: VNDA) today announced that it has named Timothy Williams as Vanda’s Senior Vice President, General Counsel and Secretary.

August 13, 2018
·
1 min read
Business

VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update

VolitionRx Limited announced financial results and a business update for the quarter ended June 30, 2018.

August 13, 2018
·
9 min read
Deals

Bruker Announces Quarterly Dividend will be Paid on September 21, 2018

Bruker Corporation announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock.

August 13, 2018
·
1 min read